The FDA approved new COVID-19 vaccines from Pfizer and Moderna on Thursday ahead of the 2024-2025 fall and winter respiratory virus season, and Novavax said it’s still working with the FDA to ...
A third player in the market, Novavax, filed for approval of a non-mRNA vaccine based on the earlier JN.1 variant before the FDA asked manufacturers to switch to KP.2. However, it said it is ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
The World Health Organization (WHO) has issued an emergency approval for the Novavax drug against COVID-19, which has thus become the 10th vaccine available in the fight against the rapidly ...